Please assess the completion status of the following clinical trial:

Trial Title: Impact of 0.1% and 0.2% Sodium Hyaluronate on Postoperative Discomfort Following Phacoemulsification Surgery

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: PREVENTION
- Time Perspective: None
- Masking: SINGLE
- Phase: None
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~* Diagnosis of senile cataract with stage 2 or 3 nuclear opalescence according to the - Lens Opacities Classification System III (LOCS-3) grading scale~Exclusion Criteria:~1. Diagnosis or evidence of dry-eye-disease (DED)~2. IOP-lowering medications~3. Former incisional surgery~4. Former diagnosis of corneal disease~5. Diabetes~6. Autoimmune diseases~7. Mental diseases

- Gender: ALL
- Minimum Age: 50 Years
- Maximum Age: 85 Years
- Healthy Volunteers: f

Study Arms:
- Study group (Type: ACTIVE_COMPARATOR): Sodium Hyaluronate 0.1% drops
- Control group (Type: ACTIVE_COMPARATOR): Sodium Hyaluronate 0.2% drops

Based on this trial design, predict the completion outcome and termination type (if applicable).